Timothy Eugene Sullivan Apellis Pharmaceuticals, Inc. (APLS) insider trading activity
Timothy Eugene Sullivan is Chief Financial Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 128,665 shares of APLS, which is worth approximately $2.35 Million. The most recent transaction as insider was on Feb 21, 2023, when has been sold 11,683 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
129K
0%
3M change
62.51%
12M change
Total Value Held
$2.35 Million
Timothy Eugene Sullivan Transaction History
TES
Timothy Eugene Sullivan
Chief Financial Officer
Waltham, MA